Showing 1 - 8 results of 8 for search 'Chul-Won Jung', query time: 0.03s Refine Results
  1. 1
    Rare Case of Germline GATA2‐Deficiency With Merkel Cell Carcinoma and Acute Myeloid Leukemia

    Rare Case of Germline GATA2‐Deficiency With Merkel Cell Carcinoma and Acute Myeloid Leukemia by SooHo Yu, Min‐Seung Park, Gyu Yeong Kim, Junhun Cho, Chul Won Jung, Hee‐Jin Kim, Hyun‐Young Kim

    Published 2024-12-01
    Get full text
    Article
  2. 2
    Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding

    Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding by Jae Won Yun, Ki-O Lee, Chul Won Jung, Soo-Young Oh, Sun-Hee Kim, Chul Won Choi, Hee-Jin Kim

    Published 2019-06-01
    Get full text
    Article
  3. 3
    Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia

    Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia by Dong Hwan Kim, Suzanne Kamel-Reid, Hong Chang, Robert Sutherland, Chul Won Jung, Hyeoung-Joon Kim, Je-Jung Lee, Jeffrey H. Lipton

    Published 2009-01-01
    Get full text
    Article
  4. 4
    Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population

    Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general popu... by Hee-Jin Kim, Ja-Young Seo, Ki-O Lee, Sung-Hwan Bang, Seung-Tae Lee, Chang-Seok Ki, Jong-Won Kim, Chul Won Jung, Duk-Kyung Kim, Sun-Hee Kim

    Published 2014-03-01
    Get full text
    Article
  5. 5
    Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

    Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype by Jae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, Sung-Hoon Jung, Deok-Hwan Yang, Je-Jung Lee, Il-Kwon Lee, Nan Young Kim, Mark D Minden, Chul Won Jung, Jun-Ho Jang, Hee Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung-Hyun Kim, Namshin Kim, Kenichi Yoshida, Seishi Ogawa, Dennis Dong Hwan Kim

    Published 2015-09-01
    Get full text
    Article
  6. 6
    Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

    Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study by Seok Jin Kim, Jong Wook Lee, Chul Won Jung, Chang Ki Min, Bin Cho, Ho Jin Shin, Joo Seop Chung, Hawk Kim, Won Sik Lee, Young Don Joo, Deok-Hwan Yang, Hoon Kook, Hyoung Jin Kang, Hyo Seop Ahn, Sung-Soo Yoon, Sang Kyun Sohn, Yoo Hong Min, Woo-Sung Min, Hee-Sook Park, Jong Ho Won

    Published 2010-11-01
    Get full text
    Article
  7. 7
    Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia

    Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia by Ga-Young Song, Hyeon-Jong Kim, TaeHyung Kim, Seo-Yeon Ahn, Sung-Hoon Jung, Mihee Kim, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, June-Won Cheong, Chul Won Jung, Jun Ho Jang, Hee- Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Seong Kyu Park, Sung-Hyun Kim, Chang Kyun Choi, Hyeoung-Joon Kim, Jae-Sook Ahn, Dennis Dong Hwan Kim

    Published 2024-04-01
    Get full text
    Article
  8. 8
    Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

    Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial by Hartmut Döhner, Argiris Symeonidis, Dries Deeren, Judit Demeter, Miguel A. Sanz, Achilles Anagnostopoulos, Jordi Esteve, Walter Fiedler, Kimmo Porkka, Hee-Je Kim, Je-Hwan Lee, Kensuke Usuki, Stefano D'Ardia, Chul Won Jung, Olga Salamero, Heinz-August Horst, Christian Recher, Philippe Rousselot, Irwindeep Sandhu, Koen Theunissen, Felicitas Thol, Konstanze Döhner, Veronica Teleanu, Daniel J. DeAngelo, Tomoki Naoe, Mikkael A. Sekeres, Valerie Belsack, Miaomiao Ge, Tillmann Taube, Oliver G. Ottmann

    Published 2021-08-01
    Get full text
    Article

Search Tools: